
Problem-Based Approach to IHC Lab Directorship
November 18, 2026 | Webinar Recording
Watch the Webinar Recording
Access the recording of this educational webinar.
Register & Watch WebinarSession Description
This webinar will explore practical approaches to identifying, investigating, and mitigating changes in immunohistochemical (IHC) assay performance. Drawing on three cases from an academic pathology laboratory, the session will address challenges that laboratory personnel and directors may encounter in practice.
- Urgent optimization and revalidation of a breast ER immunohistochemical assay. Attendees will learn how cell-line microarrays and bead calibrators can aid in predictive marker optimization.
- Paraffin pooling after a formulation change affected PD-L1 staining. A new paraffin formulation unexpectedly affected PD-L1 staining performance, prompting a systematic investigation and corrective action plan. This case examines how pre-analytic factors can alter assay performance and how communication within the laboratory supports troubleshooting.
- Validation of EDTA-based decalcification protocols. Attendees will learn how the laboratory validated EDTA decalcification for immunohistochemistry.
The session will draw practical lessons from these cases with a focus on maintaining assay robustness, ensuring reproducibility, and supporting high-quality patient care.
Learning Objectives
- Apply contemporary validation and optimization tools, including cell-line microarrays and calibrator-based approaches, to aid in predictive immunohistochemical assays.
- Recognize and investigate pre-analytic factors that can adversely affect immunohistochemical assay performance, including unexpected effects related to paraffin formulation changes and tissue processing.
- Design and implement validation for EDTA-based decalcification methods to support reliable immunohistochemical testing while maintaining assay accuracy and reproducibility.
Target Audience
Pathologists, laboratory directors, technical supervisors, and histology professionals interested in assay validation, quality assurance, and the real-world challenges of implementing and maintaining reliable immunohistochemical testing in contemporary practice.
About the Speaker
Matthew Gosse, MD, is a Clinical Assistant Professor of Pathology at the University of Iowa Health Care (UIHC), where he specializes in gastrointestinal, hepatobiliary, neuroendocrine, and renal pathology. He serves as a surgical pathologist and is actively involved in diagnostic immunohistochemistry, biomarker development, and laboratory assay validation. Dr. Gosse is the medical director of the immunohistochemistry laboratory at UIHC and Co-Director of the Biospecimens Core for the Iowa Neuroendocrine Tumor SPORE.
Dr. Gosse’s academic interests focus on the application of immunohistochemistry and molecular pathology to solve challenging diagnostic problems, particularly in carcinomas of unknown primary origin, neuroendocrine neoplasms, and gastrointestinal cancers. His research has contributed to the validation and clinical implementation of novel biomarkers and digital pathology approaches.
An active educator, Dr. Gosse directs multiple pathology training programs at the University of Iowa, including the post-sophomore pathology externship, medical student surgical pathology clerkship, and gastrointestinal pathology resident rotation. He also serves on the Editorial Board of Applied Immunohistochemistry & Molecular Morphology.
